Your browser doesn't support javascript.
loading
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Sharma, Rohini; Pillai, Anjana; Marron, Thomas Urban; Fessas, Petros; Saeed, Anwaar; Jun, Tomi; Dharmapuri, Sirish; Szafron, David; Naqash, Abdul Rafeh; Gampa, Anuhya; Wang, Yinghong; Khan, Uqba; Muzaffar, Mahvish; Lee, Chieh-Ju; Lee, Pei-Chang; Bulumulle, Anushi; Paul, Sonal; Bettinger, Dominic; Hildebrand, Hannah; Yehia, Mohammed; Pressiani, Tiziana; Kaseb, Ahmed; Huang, Yi-Hsiang; Ang, Celina; Kudo, Masatoshi; Nishida, Naoshi; Personeni, Nicola; Rimassa, Lorenza; Pinato, David James.
Afiliación
  • Sharma R; Department of Surgery & CancerImperial College LondonHammersmith HospitalLondonUK.
  • Pillai A; Section of Gastroenterology, Hepatology and NutritionThe University of Chicago MedicineChicagoIllinoisUSA.
  • Marron TU; Department of MedicineDivision of Hematology/OncologyTisch Cancer InstituteMount Sinai HospitalNew YorkNew YorkUSA.
  • Fessas P; Department of Surgery & CancerImperial College LondonHammersmith HospitalLondonUK.
  • Saeed A; Division of Medical OncologyGI Oncology ProgramKansas University Cancer CentreKansas CityKansasUSA.
  • Jun T; Department of MedicineDivision of Hematology/OncologyTisch Cancer InstituteMount Sinai HospitalNew YorkNew YorkUSA.
  • Dharmapuri S; Department of MedicineDivision of Hematology/OncologyTisch Cancer InstituteMount Sinai HospitalNew YorkNew YorkUSA.
  • Szafron D; Department of MedicineBaylor College of MedicineHoustonTexasUSA.
  • Naqash AR; Division of Cancer Treatment and DiagnosisNational Cancer InstituteBethesdaMarylandUSA.
  • Gampa A; Section of Gastroenterology, Hepatology and NutritionThe University of Chicago MedicineChicagoIllinoisUSA.
  • Wang Y; Department of GastroenterologyHepatology & NutritionThe University of Texas MD Anderson Cancer CenterHoustonTexasUSA.
  • Khan U; Department of medicineLincoln Medical CenterWeill Cornell/New York Presbyterian HospitalNew YorkNew YorkUSA.
  • Muzaffar M; Division of Hematology/ OncologyEast Carolina UniversityGreenvilleNorth CarolinaUSA.
  • Lee CJ; Division of Gastroenterology and HepatologyDepartment of MedicineTaipei Veterans General HospitalTaipeiTaiwan.
  • Lee PC; Division of Gastroenterology and HepatologyDepartment of MedicineTaipei Veterans General HospitalTaipeiTaiwan.
  • Bulumulle A; Division of Hematology/ OncologyEast Carolina UniversityGreenvilleNorth CarolinaUSA.
  • Paul S; New York Presbyterian Brooklyn Methodist HospitalNew YorkNew YorkUSA.
  • Bettinger D; Department of Medicine IIFaculty of MedicineMedical Center University of FreiburgUniversity of FreiburgFreiburgGermany.
  • Hildebrand H; Berta-Ottenstein ProgrammeFaculty of MedicineMedical Center University of FreiburgUniversity of FreiburgFreiburgGermany.
  • Yehia M; Division of Medical OncologyGI Oncology ProgramKansas University Cancer CentreKansas CityKansasUSA.
  • Pressiani T; Department of Gastrointestinal Medical OncologyThe University of Texas MD Anderson Cancer CenterHoustonTexasUSA.
  • Kaseb A; Medical Oncology and Hematology UnitHumanitas Cancer CenterHumanitas Clinical and Research Center - IRCCSRozzano, MilanItaly.
  • Huang YH; Department of Gastrointestinal Medical OncologyThe University of Texas MD Anderson Cancer CenterHoustonTexasUSA.
  • Ang C; Division of Gastroenterology and HepatologyDepartment of MedicineTaipei Veterans General HospitalTaipeiTaiwan.
  • Kudo M; Department of MedicineDivision of Hematology/OncologyTisch Cancer InstituteMount Sinai HospitalNew YorkNew YorkUSA.
  • Nishida N; Department of Gastroenterology and HepatologyKindai University Faculty of MedicineOsaka-sayama, OsakaJapan.
  • Personeni N; Department of Gastroenterology and HepatologyKindai University Faculty of MedicineOsaka-sayama, OsakaJapan.
  • Rimassa L; Medical Oncology and Hematology UnitHumanitas Cancer CenterHumanitas Clinical and Research Center - IRCCSRozzano, MilanItaly.
  • Pinato DJ; Department of Biomedical SciencesHumanitas UniversityPieve Emanuele, MilanItaly.
Hepatol Commun ; 6(7): 1776-1785, 2022 07.
Article en En | MEDLINE | ID: mdl-35481940
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatol Commun Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatol Commun Año: 2022 Tipo del documento: Article